Showing results (31-40 of 39) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Revista Espanola De Cardiologia (English Ed.)|August 6, 2016
Comparative Evaluation of Four Risk Scores for Predicting Mortality in Patients With Implantable Cardioverter-defibrillator for Primary PreventionMoisés Rodríguez-Mañero, Emad Abu Assi, Juan Miguel Sánchez-Gómez, et al.
JMIR Cardio|March 18, 2026
Short-Term Arrhythmia Prediction Using AI Based on Daily Data From Implantable Devices: Multicenter Prospective Observational StudyIgnacio Fernández Lozano, Joaquín Fernández de la Concha, Javier Ramos Maqueda, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|August 31, 2025
Cost-effectiveness of Apixaban vs Aspirin for the Reduction of Thrombo-Embolism in High-Risk Patients with Device-Detected Atrial Fibrillation: Insights from the ARTESiA trialAndre Lamy, Roopinder K Sandhu, Wesley Tong, et al.
European Journal of Heart Failure|April 13, 2026
Subclinical atrial fibrillation and the risk of heart failure: insights from ARTESiAMaria Hee Jung Park Frausing, William F McIntyre, Jeff S Healey, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|April 8, 2017
Long-term prognosis of patients with life-threatening ventricular arrhythmias induced by coronary artery spasmMoisés Rodríguez-Mañero, Teresa Oloriz, Jean-Benoit le Polain de Waroux, et al.
Journal of the American College of Cardiology|July 17, 2024
Apixaban vs Aspirin According to CHA2DS2-VASc Score in Subclinical Atrial Fibrillation: Insights From ARTESiARenato D Lopes, Christopher B Granger, Daniel M Wojdyla, et al.
European Heart Journal|September 2, 2024
Anticoagulation in device-detected atrial fibrillation with or without vascular disease: a combined analysis of the NOAH-AFNET 6 and ARTESiA trialsRenate B Schnabel, Juan Benezet-Mazuecos, Nina Becher, et al.
The New England Journal of Medicine|November 12, 2023
Apixaban for Stroke Prevention in Subclinical Atrial FibrillationJeff S Healey, Renato D Lopes, Christopher B Granger, et al.
Revista Espanola De Cardiologia (English Ed.)|September 23, 2024
Spanish catheter ablation registry. 23rd official report of the Heart Rhythm Association of the Spanish Society of Cardiology (2023)Victor Bazan, Eduardo Arana, José Manuel Rubio-Campal, et al.
Pageof 4